Document is current
Any future updates will be listed below
-
Authors
Yudiski, Alexandra
Rocha, Heather
Liu, Edward
Dzeda, Matthew
Granja, Olivia
Haynes, Nicholas
Woolley, Hannah
Conklin, Shane
Shermanski, Gabrielle
Leicht, Amanda
Morland, Thomas
Wu, Kathie
Confer, Bradley
- License Information
-
More Information
Article History
Received: 22 July 2025
Accepted: 20 January 2026
First Online: 9 February 2026
Declarations
:
: No funding was received for conducting this study. Author Thomas Morland has received research support and has intellectual property interest from Tempus Labs, Inc. Author Thomas Morland also has an immediate family member that holds employment and is a shareholder of the United Therapeutics Corporation. Author Bradley Confer has been a consultant for Boston Scientific Corporation and participated in speaker’s bureau at Abbvie. Author Hannah Woolley has an immediate family member who owns stock in Alcon, Novartis, Gilead Sciences, Regeneron, Amgen, Pfizer, Vertex Pharmaceutical, Biogen, BioNTech, and Moderna Therapeutics. Author Heather Rocha has an immediate family member who is employed by New York Presbyterian Hospital. All other authors have no relevant financial or non-financial interests to disclose.
: Ethical approval was waived by IRB of Geisinger in view of the retrospective nature of the study and all the interventions being performed were part of the routine care.
